2021 EAEU regulatory changesJanuary 15, 2021
2021 EAEU regulatory changes
Are you ready for 2021 EAEU regulatory changes?
Effective as of January 10, 2021, the registration of medicines in the Russian Federation carries out only in accordance with EAEU rules (Decision of the EEC Council No. 128 of December 23, 2020).
For other EAEU countries, the registration of medicines under national procedures has been extended until July 1, 2021.
Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS, and EU markets in the field of regulatory services for pharmaceutical companies.
If you want to find out more information about EAEU registration rules, please contact us at firstname.lastname@example.org.
Webinar: EAEU Regulatory Challenges and OpportunitiesNovember 09, 2020
Readability user testing is requested in EAEUOctober 15, 2020
Inpharmatis & Epista Partnership AnnouncementSeptember 03, 2020
User Testing Instructions Webinar on 30 April in RussianApril 27, 2020
Inpharmatis Team COVID-19 UpdateMarch 30, 2020
Inpharmatis - Winner in EU GMP Inspection TenderMarch 19, 2020
Bебинар: Регистрация и создание досье в электронном формате по новым стандартам ЕАЭСDecember 09, 2019
The EAEU Electronic Submission FormatNovember 20, 2019
Meet us at IV All-Russia GMP Conference 2019September 23, 2019